The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Will Be The Estimated Market Valuation Of The Prostate Health Market By The End Of 2030?
The market size for prostate health has demonstrated significant expansion in recent years. It is anticipated to increase from $37.23 billion in 2025 to $40.69 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.3%. The historical period’s growth can be ascribed to a burgeoning aging male demographic, an increasing occurrence of benign prostate conditions, enhanced access to urology services, the availability of pharmacological solutions for prostate health, and heightened health awareness among males.
The prostate health market is projected to experience substantial growth over the next few years. It is anticipated to reach a value of $57.39 billion by 2030, with a compound annual growth rate (CAGR) of 9.0%. This expansion during the forecast period is fueled by factors such as the increasing adoption of personalized prostate care plans, the rising utilization of digital health platforms, the broadening of preventive healthcare programs, a growing demand for minimally invasive therapies, and an increased emphasis on long-term prostate wellness. Significant trends expected in the forecast period include a heightened focus on preventive prostate healthcare, the increasing acceptance of non-invasive treatment options, a surging demand for lifestyle and nutritional interventions, the proliferation of digital health monitoring solutions, and a strengthened commitment to early screening and awareness.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21265&type=smp
Which Market Drivers Are Supporting The Expansion Of The Prostate Health Market?
The increasing occurrence of prostate cancer is anticipated to fuel expansion within the prostate health market in the future. Prostate cancer involves the uncontrolled proliferation of cells within the prostate gland, frequently appearing as adenocarcinomas, which represent the predominant manifestation of this condition in males. This upward trend in prostate cancer cases is largely attributed to an expanding older demographic, more widespread screening procedures, and lifestyle elements like excess weight and limited physical activity. Maintaining prostate health is crucial for preventing, promptly identifying, and effectively managing prostate cancer. As an illustration, the American Cancer Society (ACS), a US-based non-profit entity, reported in January 2023 that an estimated 288,300 new prostate cancer diagnoses were projected for the U.S. in 2023, alongside approximately 34,700 deaths from the illness. Consequently, the growing incidence of prostate cancer is set to stimulate the expansion of the prostate health market.
Which Segment Classifications Shape The Prostate Health Market?
The prostate health market covered in this report is segmented –
1) By Disease Indication: Prostate Cancer, Benign Prostate Hyperplasia, Prostatitis
2) By Treatment: Hormonal Therapy, Chemotherapy, Surgical Treatments, Other Treatments
3) By Distribution Channel: E-Commerce Stores, Pharmacies, Other Distribution Channels
Subsegments:
1) By Prostate Cancer: Localized Prostate Cancer, Metastatic Prostate Cancer
2) By Benign Prostate Hyperplasia: Mild BPH, Moderate BPH, Severe BPH
3) By Prostatitis: Acute Bacterial Prostatitis, Chronic Bacterial Prostatitis, Chronic Prostatitis (Non-Bacterial)
What Trends Are Projected To Affect The Prostate Health Market?
Leading companies within the prostate health market are increasingly concentrating on technological advancements, such as AI-powered risk assessment, to secure a competitive advantage. This AI-powered risk assessment employs artificial intelligence algorithms to process data and forecast potential risks, thereby aiding in the formation of educated decisions and the enhancement of outcomes. As an illustration, in September 2024, Nanostics Inc., a Canadian clinical-stage biotechnology company, collaborated with Protean BioDiagnostics, a US-based biotechnology firm, to introduce CDX Prostate. This diagnostic tool is designed for men at risk of aggressive prostate cancer and integrates biological data, clinical information, and AI-powered learning models to compute an aggressive prostate cancer risk score. CDX Prostate leverages advanced machine learning algorithms for analyzing a range of biological and clinical data, offering a more precise risk score for aggressive prostate cancer in contrast to older methods. The test empowers healthcare providers and patients to make well-informed decisions concerning whether to proceed with a biopsy after an elevated prostate-specific antigen (PSA) test result or an irregular digital rectal exam (DRE).
Which Companies Are Expanding Their Footprint In The Prostate Health Market?
Major companies operating in the prostate health market are Pfizer Inc, Johnson And Johnson, Bayer AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Co Ltd, Astellas Pharma Inc, Genentech Inc, Teleflex Inc, Elekta AB, Myriad Genetics Inc, Freenome, Theragenics Corporation, Roivant Sciences, Artera Inc, Veru Inc, HistoSonics Inc, Immunic Inc, Ezra, Francis Medical, Lucida Medical, Serimmune Inc, Alessa Therapeutics
Read the full prostate health market report here:
https://www.thebusinessresearchcompany.com/report/prostate-health-global-market-report
How Is The Prostate Health Market Distributed Across Key Geographic Regions?
North America was the largest region in the prostate health market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate health market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Prostate Health Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=21265&type=smp
Browse Through More Reports Similar to the Global Prostate Health Market 2026, By The Business Research Company
Prostate Cancer Diagnostics Global Market Report
https://www.thebusinessresearchcompany.com/report/prostate-cancer-diagnostics-global-market-report
Nuclear Medicine Diagnostics Global Market Report
https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report
Prostate Cancer Drugs Global Market Report
https://www.thebusinessresearchcompany.com/report/prostate-cancer-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model